Machine-learning models created by a National Institutes of Health (NIH)-supported research team can identify, with high accuracy, patients likely to have long COVID, according to a study yesterday in The Lancet Digital Health.
Recent evidence shows one-dose regimens perform just as well as two- or three-dose schedules.
Two US outbreaks of Salmonella, one S Typhimurium and the other S Infantis, have been linked to Italian-style meats, although none are connected to a specific product or brand yet, according to a Centers for Disease Control and Prevention (CDC) investigation notice today.
A crowdsourcing appeal for creative solutions for safely reopening the University of North Carolina at Chapel Hill amid the COVID-19 pandemic in fall 2020 netted 82 submissions from 110 students, faculty, and staff, according to a qualitative study today in JAMA Network Open.
Multisystem inflammatory syndrome in children (MIS-C), which has been linked with pediatric COVID-19, may pose higher risks to children in lower socioeconomic statuses or who are minorities, according to a Pediatrics study today.
CARB-X announced today that it is awarding up to $3.6 million in funding to Novel Microdevices, Inc. of Baltimore to develop a rapid, portable molecular diagnostic test for sexually transmitted bacterial infections.
Since the introduction of the human papillomavirus (HPV) vaccine in 2006, rates of HPV infections among females fell 88% in teens 14 to 19 years and by 81% in those aged 20 to 24 by 2018, according to a study today in Morbidity and Mortality Weekly Report (MMWR).
Unemployment insurance was tied to a food insecurity reduction of 4.3 percentage points and a reduction in the need to eat less because of financial constraints of 5.7 percentage points during the COVID-19 pandemic, according to a JAMA Network Open study published late last week.
COVID-19 patients diagnosed as having schizophrenia spectrum disorder—but not those with mood or anxiety disorders—were linked to an increased risk of death, according to an observational cohort study published today in JAMA Psychiatry.
A study shows four out of five people with recent loss of smell and/or taste tested positive for COVID-19 antibodies, and 39.8% of those did not have a cough or fever.